Get the Stockscreener App
19.60
1.37%
+0.3832
Myriad Genetics, Inc. Stock (MYGN) Forecast
The Myriad Genetics, Inc. (MYGN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $16.53, representing a -15.67% decrease from the current price of $19.60. The highest analyst price target is $19.46, and the lowest is $13.60.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MYGN Price Target
Average 20.35
(+3.79% Upside)
Is Myriad Genetics, Inc. (MYGN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 50.86 | Neutral |
| STOCH(9,6) | 68.81 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.4009 | Buy |
| ADX(14) | 23.39 | Neutral |
| William %R | -15.07 | Sell |
| CCI(14) | 129.98 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
18.97
Buy
|
19.24
Buy
|
| MA20 |
19.25
Buy
|
19.44
Buy
|
| MA50 |
20.76
Sell
|
20.17
Sell
|
| MA100 |
20.81
Sell
|
20.21
Sell
|
| MA200 |
19.08
Buy
|
20.07
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, MYGN could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on MYGN, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 50.86 indicates that MYGN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 68.81 indicates that MYGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that MYGN is oversold. This suggests that MYGN price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.39 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 129.98 indicates that MYGN is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term MYGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Myriad Genetics, Inc. financial reports and earnings history, Myriad Genetics, Inc. (MYGN) stock could reach $10.55 by 2030, $4.3564 by 2040 and $10.70 by 2050. See the projected annual prices until 2050 of the Myriad Genetics, Inc. stock below:
- Myriad Genetics, Inc. (MYGN) is expected to reach an average price of $5.6409 in 2035, with a high prediction of $6.9404 and a low estimate of $1.3699. This indicates an $-71.22% rise from the last recorded price of $19.60.
- Myriad Genetics, Inc. (MYGN) stock is projected to chart a bullish course in 2040, with an average price target of $1.8163, representing an $-90.73% surge from its current level. The forecast ranges from a conservative $1.0936 to a sky-high $4.3564.
- Our analysts predict Myriad Genetics, Inc. (MYGN) to jump -61.66% by 2045, soaring from $6.6428 to an average price of $7.5163, potentially reaching $7.0718. While $6.6428 is the low estimate, the potential upside is significant.
- Myriad Genetics, Inc. (MYGN) stock is expected to climb by 2050, reaching an average of $9.3546, a $-52.28% jump from its current level. However, a wide range of estimates exists, with high and low targets of $10.70 and $11.44, respectively, highlighting the market's uncertainty.
Myriad Genetics, Inc. Stock (MYGN) Year by Year Forecast
Myriad Genetics, Inc. Stock (MYGN) Price Forecast for 2024
Our forecast for MYGN stock price in 2024 now indicates an average price target of $25.69 with a high forecast of $39.57 and a low forecast of $11.81. The average prediction reflects an increase of +31.04% from the last recorded price of $19.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $19.24 | $13.60 | $19.46 | -1.87% |
| July, 2024 | $21.05 | $16.54 | $21.17 | +7.36% |
| August, 2024 | $14.01 | $14.01 | $39.57 | -28.52% |
| September, 2024 | $18.70 | $13.65 | $20.53 | -4.59% |
| October, 2024 | $22.42 | $18.26 | $22.86 | +14.38% |
| November, 2024 | $15.30 | $11.81 | $26.73 | -21.97% |
| December, 2024 | $17.39 | $15.27 | $18.44 | -11.28% |
Myriad Genetics, Inc. Stock (MYGN) Price Forecast for 2025
Myriad Genetics, Inc. Stock (MYGN) is expected to reach an average price of $11.54 in 2025, with a high prediction of $21.95 and a low estimate of $1.1248. This indicates an -41.14% fall from the last recorded price of $19.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $18.66 | $16.21 | $20.47 | -4.80% |
| February, 2025 | $19.44 | $18.24 | $21.71 | -0.84% |
| March, 2025 | $8.8882 | $8.5182 | $21.95 | -54.66% |
| April, 2025 | $5.9726 | $1.1248 | $10.54 | -69.53% |
| May, 2025 | $7.0681 | $3.9614 | $8.1703 | -63.94% |
| June, 2025 | $6.7036 | $5.2447 | $8.1036 | -65.80% |
| July, 2025 | $4.1879 | $3.5741 | $8.9193 | -78.64% |
| August, 2025 | $3.5234 | $2.5669 | $4.7768 | -82.03% |
| September, 2025 | $4.2789 | $3.1648 | $4.7389 | -78.17% |
| October, 2025 | $4.5233 | $3.9433 | $7.1567 | -76.93% |
| November, 2025 | $5.2088 | $3.9199 | $6.121 | -73.43% |
| December, 2025 | $4.7032 | $3.9754 | $7.1132 | -76.01% |
Myriad Genetics, Inc. Stock (MYGN) Price Forecast for 2026
The predicted value for Myriad Genetics, Inc. (MYGN) in 2026 is set at an average of $17.18. Estimates vary from a peak of $29.58 to a trough of $4.772, indicating an -12.37% surge from the present price of $19.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $10.03 | $4.772 | $11.07 | -48.84% |
| February, 2026 | $10.29 | $9.4375 | $12.42 | -47.49% |
| March, 2026 | $19.03 | $9.693 | $19.66 | -2.93% |
| April, 2026 | $23.70 | $17.24 | $23.95 | +20.92% |
| May, 2026 | $22.89 | $19.14 | $24.94 | +16.76% |
| June, 2026 | $20.60 | $19.39 | $26.41 | +5.06% |
| July, 2026 | $19.86 | $17.02 | $24.47 | +1.31% |
| August, 2026 | $22.24 | $18.57 | $22.59 | +13.48% |
| September, 2026 | $25.69 | $21.04 | $25.73 | +31.05% |
| October, 2026 | $27.04 | $22.27 | $28.66 | +37.96% |
| November, 2026 | $28.41 | $24.86 | $29.58 | +44.93% |
| December, 2026 | $24.98 | $23.48 | $29.55 | +27.45% |
Myriad Genetics, Inc. Stock (MYGN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Myriad Genetics, Inc. (MYGN) is $17.43, with a high forecast of $25.79 and a low forecast of $9.0762. This indicates an -11.07% decrease from the last price of $19.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $25.21 | $23.21 | $25.79 | +28.60% |
| February, 2027 | $20.81 | $20.37 | $25.40 | +6.13% |
| March, 2027 | $17.66 | $16.34 | $21.27 | -9.91% |
| April, 2027 | $20.62 | $16.98 | $21.27 | +5.16% |
| May, 2027 | $18.01 | $16.48 | $20.89 | -8.12% |
| June, 2027 | $15.58 | $15.35 | $20.36 | -20.55% |
| July, 2027 | $18.14 | $15.26 | $20.67 | -7.46% |
| August, 2027 | $14.95 | $14.56 | $19.40 | -23.76% |
| September, 2027 | $16.14 | $11.98 | $16.35 | -17.66% |
| October, 2027 | $9.6062 | $9.0762 | $15.82 | -51.00% |
| November, 2027 | $12.75 | $9.7451 | $12.94 | -34.95% |
| December, 2027 | $20.75 | $12.06 | $21.32 | +5.83% |
Myriad Genetics, Inc. Stock (MYGN) Price Forecast for 2028
In 2028, Myriad Genetics, Inc. (MYGN) is projected to reach an average price of $14.16, with a high projection of $21.06 and a low estimate of $7.2602. This indicates an -27.75% fall from the last price of $19.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $14.99 | $14.79 | $21.06 | -23.53% |
| February, 2028 | $12.29 | $11.23 | $16.71 | -37.32% |
| March, 2028 | $13.99 | $11.37 | $14.31 | -28.63% |
| April, 2028 | $12.93 | $8.6403 | $15.44 | -34.06% |
| May, 2028 | $8.9713 | $8.8013 | $14.30 | -54.24% |
| June, 2028 | $13.72 | $7.2602 | $13.76 | -30.03% |
| July, 2028 | $12.05 | $11.57 | $15.09 | -38.52% |
| August, 2028 | $14.68 | $11.26 | $17.33 | -25.13% |
| September, 2028 | $16.81 | $14.22 | $17.51 | -14.24% |
| October, 2028 | $12.81 | $11.83 | $17.23 | -34.67% |
| November, 2028 | $16.99 | $10.87 | $17.14 | -13.32% |
| December, 2028 | $16.78 | $15.13 | $17.81 | -14.41% |
Myriad Genetics, Inc. Stock (MYGN) Price Forecast for 2029
The 2029 price forecast for Myriad Genetics, Inc. Stock (MYGN) is $12.83 on average, with a high prediction of $18.07 and a low estimate of $7.5861. This represents an -34.56% decrease from the previous price of $19.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $15.99 | $15.20 | $17.11 | -18.42% |
| February, 2029 | $11.38 | $10.08 | $16.12 | -41.96% |
| March, 2029 | $10.32 | $8.844 | $12.03 | -47.34% |
| April, 2029 | $8.2884 | $8.2184 | $11.32 | -57.72% |
| May, 2029 | $10.24 | $7.5861 | $13.15 | -47.75% |
| June, 2029 | $13.06 | $9.9016 | $13.70 | -33.39% |
| July, 2029 | $13.00 | $11.64 | $16.01 | -33.67% |
| August, 2029 | $15.30 | $11.06 | $16.76 | -21.96% |
| September, 2029 | $16.66 | $14.67 | $17.68 | -15.00% |
| October, 2029 | $16.23 | $14.55 | $17.70 | -17.22% |
| November, 2029 | $12.52 | $12.23 | $16.27 | -36.12% |
| December, 2029 | $10.92 | $9.02 | $18.07 | -44.29% |
Myriad Genetics, Inc. Stock (MYGN) Price Forecast for 2030
Myriad Genetics, Inc. Stock (MYGN) is expected to reach an average price of $15.72 in 2030, with a high forecast of $31.13 and a low forecast of $0.3058. This signifies an -19.81% decrease from the last price of $19.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.0187 | $6.0332 | $10.55 | -64.20% |
| February, 2030 | $8.8297 | $5.1142 | $11.40 | -54.96% |
| March, 2030 | $30.17 | $8.3975 | $31.13 | +53.90% |
| April, 2030 | $6.6817 | $5.2517 | $30.27 | -65.92% |
| May, 2030 | $11.98 | $6.3895 | $14.49 | -38.91% |
| June, 2030 | $15.64 | $10.90 | $16.59 | -20.21% |
| July, 2030 | $8.6702 | $3.5147 | $18.43 | -55.77% |
| August, 2030 | $10.86 | $7.9633 | $11.11 | -44.59% |
| September, 2030 | $11.78 | $8.1231 | $12.25 | -39.92% |
| October, 2030 | $3.1209 | $3.0429 | $13.78 | -84.08% |
| November, 2030 | $3.7881 | $0.3058 | $4.0187 | -80.68% |
| December, 2030 | $4.0371 | $2.6949 | $2.5904 | -79.41% |
0.15%
2.75%
Cap:
|
Volume (24h):